Macropore targets growth markets with implants
This article was originally published in Clinica
Executive Summary
Macropore, a $6.25 million turnover company which develops resorbable bone-healing implants for craniofacial applications, is expected to see revenues increase to $34 million in 2002 as new applications of its technology are exploited. The San Diego company's products are distributed by Medtronic, which has a 7% stake in Macropore.